Back to Search Start Over

Impact of smoking on recurrence rates among wide-neck intracranial aneurysms treated with Woven EndoBridge: a multicenter retrospective study.

Authors :
Vaishnav D
Essibayi MA
Musmar B
Adeeb N
Salim HA
Aslan A
Cancelliere NM
McLellan RM
Algin O
Ghozy S
Lay SV
Guenego A
Renieri L
Carnevale J
Saliou G
Mastorakos P
El Naamani K
Shotar E
Premat K
Möhlenbruch M
Kral M
Doron O
Chung C
Salem MM
Lylyk I
Foreman PM
Vachhani JA
Shaikh H
Župančić V
Hafeez MU
Catapano J
Waqas M
Ayberk G
Celal Gunes Y
Rabinov JD
Ren Y
Schirmer CM
Piano M
Kühn AL
Michelozzi C
Elens S
Starke RM
Hassan AE
Ogilvie M
Nguyen A
Jones J
Brinjikji W
Nawka MT
Psychogios M
Ulfert C
Diestro JDB
Pukenas B
Burkhardt JK
Huynh T
Martinez-Gutierrez JC
Sheth SA
Spiegel G
Tawk RG
Lubicz B
Panni P
Puri AS
Pero G
Nossek E
Raz E
Killer-Oberpfalzer M
Griessenauer CJ
Asadi H
Siddiqui A
Brook AL
Haranhalli N
Ducruet AF
Albuquerque FC
Regenhardt RW
Stapleton CJ
Kan P
Kalousek V
Lylyk P
Boddu S
Knopman J
Aziz-Sultan MA
Tjoumakaris SI
Clarençon F
Limbucci N
Cuellar-Saenz HH
Jabbour PM
Mendes Pereira V
Patel AB
Altschul DJ
Dmytriw AA
Source :
Journal of neurosurgery [J Neurosurg] 2025 Jan 31, pp. 1-9. Date of Electronic Publication: 2025 Jan 31.
Publication Year :
2025
Publisher :
Ahead of Print

Abstract

Objective: Tobacco smoking is among the factors known to significantly augment the risk of untreated intracranial aneurysm (IA) growth and rupture. Smoking appears to have a variable effect on different endovascular treatment modalities. The impact of smoking on the safety, efficacy, and outcomes of Woven EndoBridge (WEB) device use for wide-neck IAs has not been evaluated. This study aimed to investigate the outcomes of WEB devices by smoking status.<br />Methods: A retrospective multicenter analysis was conducted on the data of patients from 36 sites worldwide treated with the WEB device for intracranial saccular aneurysms. Patients were stratified based on smoking status (current, former, and never smokers). The Student t-test and chi-square test were performed for continuous and categorical variables, respectively. Multivariable logistic regression was used to adjust for confounders.<br />Results: Of 1376 patients with available smoking status, 504 were current smokers, 358 were former smokers, and 514 were never smokers. Upon adjusting for significant confounders, no association was found between smoking and recurrence outcomes (OR 1.39, 95% CI 0.69-2.80; p = 0.36), thromboembolic and hemorrhagic complications, and mortality among IAs treated with the WEB device. There was no statistically significant difference in outcomes between former and never smokers (OR 1.23, 95% CI 0.70-2.18; p = 0.46). The location of aneurysms differed between smoking groups, with former smokers having more anterior circulation aneurysms compared with current and never smokers (99.0% vs 96.9% vs 95.3%; p = 0.01). In terms of clinical symptoms, headache and dizziness were more common in the never smokers compared with current and former smokers (13.9% vs 8.9% vs 7.7%, p = 0.01).<br />Conclusions: This large-scale study suggests no significant correlation between smoking and the recurrence of IAs treated with the WEB device. Biological studies are warranted to better understand the biological impact of smoking on the growth and rupture of treated IAs.

Details

Language :
English
ISSN :
1933-0693
Database :
MEDLINE
Journal :
Journal of neurosurgery
Publication Type :
Academic Journal
Accession number :
39889291
Full Text :
https://doi.org/10.3171/2024.10.JNS241058